Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3Recruiting 3Completed 2Withdrawn 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Cardiotoxicity 4Breast Neoplasms 3Ventricular Dysfunction 1Neoplasms 1Heart Failure 1

Interventions

Fulvestrant 59Trastuzumab 49Capecitabine 47Letrozole 45pembrolizumab 41Carboplatin 41Paclitaxel 39ribociclib 38Cyclophosphamide 38pertuzumab 36abemaciclib 36Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Docetaxel 27Surveys and Questionnaires 26Tamoxifen 25Anastrozole 25exemestane 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Echocardiography × Clear all
NCT06023576 2026-05-14

A Study of Blood Pressure Control During Cancer Treatment

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
130 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT05851053 2024-05-29

BLOC-II

University Medical Center Groningen

Recruiting
455 enrolled
Breast

Breast Neoplasms, Heart Failure, Ventricular Dysfunction, Cardiotoxicity

NCT06282796 2024-02-28

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

First Hospital of China Medical University

Recruiting
600 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡